Skip to content

Dossier · AGYS · Dormant

AGYS · Agilysys, Inc. · Stock research

LOW Special situation Catalyst · ai-enterprise-software

Last analysed ·

Current thesis

Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that houses the documented lumpy-bookings risk. Narrative intact but stretched — extension into an event rather than a fresh base.

Invalidation trigger

A daily close below $98 (loses the rising 20-EMA that guided the July run off the ~$92 base); confirmed by a weekly close below $88 (June higher-low breakout shelf fails), or a 2026-07-27 Q1 print that cuts the >30% subscription-growth framing or brings revenue below double-digit YoY growth off the ~$74M Q1 FY2026 base.

Thesis status

Invalidated resolved published trigger fired How this is scored →

Latest analysis and events for AGYS —

As of 2026-07-12, orbyd's latest analysis for Agilysys, Inc. (AGYS): Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that houses the documented lumpy-bookings risk. Narrative intact but stretched — extension into an event rather than a fresh base.

Invalidation trigger: A daily close below $98 (loses the rising 20-EMA that guided the July run off the ~$92 base); confirmed by a weekly close below $88 (June higher-low breakout shelf fails), or a 2026-07-27 Q1 print that cuts the >30% subscription-growth framing or brings revenue below double-digit YoY growth off the ~$74M Q1 FY2026 base.

Most recent dated event on file: — catalyst 1d ago.

Current Thesis

Agilysys is a hospitality vertical-SaaS operator whose recovery re-rate has, over the last three weeks, turned into a pre-earnings acceleration. The stock closed $108.98 on 2026-07-10, up roughly 18% from ~$92.31 (2026-06-23) and clear of the two lowest analyst targets — Oppenheimer's $100 and Piper Sandler's $110 — while still trading under the $127.33 consensus and the $159 high (Northland). Underneath the price sits a maturing but intact story: FY2026 (reported 2026-05-18) was the 17th consecutive record revenue quarter, subscription grew +30.2% to $137.1M, and management guided FY2027 to $365–370M with subscription growth held above 30% for a third straight year. The catch is timing. This move is extension into a binary event — the Q1 FY2027 print now confirmed for 2026-07-27 after close — and that print is precisely where the company's documented lumpy-bookings failure mode has struck before.

Bullish and bearish views on Agilysys, Inc.

The model's bull view on Agilysys, Inc. (AGYS), in brief: 17th straight record quarter with mix acceleration. The bear view: The failure mode is dated and severe. The Q3 FY2025 print (2026-01-21) missed at $69.6M vs $73.1M est with a guidance cut, and shares fell ~25% intraday. POS and one-time revenue timing — not subscription — is the recurring break point, and the next print lands 2026-07-27. Price… Both cases follow in full.

Bull Case

  • 17th straight record quarter with mix acceleration. FY2026 revenue $319.3M (+15.9% YoY), recurring $205.9M (+21.1%), subscription $137.1M (+30.2%); adjusted EBITDA $67.7M at 21.2% margin, free cash flow $68.1M (+30%) — reported 2026-05-18.
  • Guidance steps up. FY2027 guide $365–370M with subscription growth held above 30% (third consecutive year) and adjusted EBITDA margin expanding toward 24% at a ~30% Q4 exit rate (2026-05-18 call).
  • Sell-side skew stays all-Buy. Oppenheimer raised its target to $100 from $90 (Outperform, ~2026-07-08); Piper Sandler carries Overweight at $110 (initiated 2026-06-02); Northland tops the range near $155–159; the $127.33 consensus implies ~17% upside from the 2026-07-10 close.
  • Margin expansion is the underwritten thesis. The 2026-07-08 fair-value rework lifted the modeled net margin to ~16.15% (from ~14.96%) and revenue growth to ~16.9% (from ~13.6%), citing subscription-driven profitability — the driver analysts are paying up for is durable margin, not just top line.
  • Bookings momentum is real. Q4 FY2026 set records: 20 new customers (19 subscription), 85 new properties, 129 cross-sells; full-year net retained recurring bookings rose +43% over the prior record (2026-05-18).

Bear Case

  • The failure mode is dated and severe. The Q3 FY2025 print (2026-01-21) missed at $69.6M vs $73.1M est with a guidance cut, and shares fell ~25% intraday. POS and one-time revenue timing — not subscription — is the recurring break point, and the next print lands 2026-07-27.
  • Price is extended into that print. Up ~18% in under three weeks into a confirmed binary, above the rising 20-EMA and the two lowest targets, on a name carrying ~10% average daily volatility. A soft quarter re-rates hard and fast.
  • sell-side is reworking the multiple lower while price runs, a divergence worth respecting.
  • Valuation prices in execution. ~79.55x trailing earnings on a $3.06B market cap leaves no cushion for a bookings air-pocket.
  • The AI layer outruns the substance. Revenue Intelligence and the Central Reservation System are beta-stage "later FY2027" — this is hospitality SaaS with an AI feature set, not AI infrastructure, and it can de-rate when AI-software sentiment rotates without anything company-specific breaking.

Setup & Price Structure

A recovery uptrend that has gone near-vertical into an event. The 52-week range is $61.50–$145.25; the stock bottomed near $61.50 in 2025, re-rated through the first half of 2026, based ~$88–92 in June, then broke out in early July to close $108.98 on 2026-07-10. Market cap $3.06B is described down ~4.9% off a local high, implying a modest pullback from the ~$114 area. Price now sits above the rising 20-EMA (~$98–100) and above Oppenheimer's $100, within reach of Piper's $110, but below the $127.33 consensus. The structure reads constructive on the weekly frame and stretched on the daily. For a fresh entry this is the wrong spot: buying +18% extension three weeks into a confirmed binary print, with a documented gap-down precedent, is chasing. The cleaner setups are a post-earnings hold above the $88–92 base after 2026-07-27, or a pullback to the rising 20-EMA that resets the risk. Standing aside into the print costs little because the narrative is maturing rather than accelerating with peer-cluster confirmation.

Catalyst Calendar (next 30 days)

  • ~2026-07-27 / 2026-07-28: Earnings call and FY2027 guidance update — Marriott PMS rollout cadence and AI-module (Revenue Intelligence, CRS) beta timing are the qualitative tells for the year's shape.

Elapsed catalysts

  • 2026-07-22 (est.): Start of the pre-print risk window — three trading days ahead of earnings, beyond which fresh entries carry unhedged binary risk into the event. (passed 6d ago)
  • 2026-07-27 (confirmed): Q1 FY2027 results after market close (quarter ended 2026-06-30). The binary. Watch revenue vs. the ~$74M Q1 FY2026 base and whether YoY growth holds double digits, the >30% subscription-growth framing, and any POS/one-time timing language that has broken prior quarters. (passed 1d ago)

What Would Change Our Mind

The recovery-uptrend read breaks on a daily close below $98, which surrenders the rising 20-EMA that has guided the July run off the ~$92 base; a weekly close below $88 confirms the failure by losing the June higher-low breakout shelf. On fundamentals, a 2026-07-27 print that cuts the >30% subscription-growth framing, brings revenue below double-digit YoY growth off the ~$74M Q1 FY2026 base, or repeats the Q3 FY2025 guidance-cut pattern would flip the story from maturing-but-intact to broken. On the other side, a post-earnings close that holds above $110 with subscription growth reaffirmed would confirm the breakout and open the path toward the $127 consensus — a post-print decision, to be made once results are in.

Correlation Notes

AGYS is an idiosyncratic small-cap ($3.06B) whose price tracks its own bookings and earnings cadence far more than index beta. Read-throughs come from hospitality and travel demand (occupancy and RevPAR trends), enterprise vertical-SaaS peers (Toast, PAR Technology) and the incumbent hospitality-software stack it displaces (Oracle OPERA/Micros, Infor), and broad software-multiple sensitivity to rates. The single largest named exposure is the Marriott PMS rollout, whose back-end-loaded cadence injects revenue-timing variance from one logo. As an AI-tagged name it also carries second-order sentiment risk: when AI-software multiples compress, feature-layer stories de-rate alongside the leaders even absent a company-specific catalyst.

Notes

  • Earnings blackout: Q1 FY2027 (quarter ended 2026-06-30) prints ~late July 2026 — avoid fresh entries inside 3 trading days of the date once confirmed.
  • Lumpy-bookings risk is real: -25% intraday on 2026-01-21 (Q3 FY2025) on a revenue miss + guide cut. POS/one-time revenue timing is the failure mode, not subscription.
  • High-beta: ~10.29% average daily volatility — size small relative to chart conviction.
  • Price below all 5 active PTs ($100/$110/$140/$159, consensus ~$127) as of 2026-06-05 close $88.42 — sell-side room intact.
  • Marriott PMS rollout (signed Dec 2022) is 2+ year, back-end loaded; management warned against expecting 'perfect rollout cadence.'
  • AI-native modules (Revenue Intelligence, CRS) are beta-stage 'later FY2027' — narrative is real but early-stage, not a core revenue driver yet.
  • Earnings blackout: Q1 FY2027 prints est. ~2026-07-27 (Investing.com); comparable Q1 FY2026 landed 2026-07-21 — avoid fresh entries inside 3 trading days once the date is confirmed (watch for scheduling release early-mid July).
  • Lumpy-bookings risk is the failure mode: -25% intraday on 2026-01-21 (Q3 FY2025) on a revenue miss + guide cut. POS/one-time revenue timing, not subscription, is what breaks.
  • High-beta: ~10% average daily volatility — size small relative to chart conviction.
  • Price ~$92.31 (2026-06-23, up from $88.42 on 2026-06-05) still below all active PTs ($110 Piper / $140 Cantor / $155-159 Northland; consensus ~$125-140) — sell-side room intact.
  • AI-native modules (Revenue Intelligence, CRS) are beta-stage 'later FY2027' — narrative real but early, not a core revenue driver yet.
  • Theme is maturing, not accelerating: re-rate off the 2025 lows is part-played; cleaner entry is a 20-EMA pullback or confirmed post-earnings hold above the $80 shelf, not a pre-print drift.
  • Earnings blackout: Q1 FY2027 CONFIRMED 2026-07-27 after close (quarter ended 2026-06-30) — avoid fresh entries inside 3 trading days; window opens ~2026-07-22.
  • Lumpy-bookings is the failure mode: -25% intraday on 2026-01-21 (Q3 FY2025) on a revenue miss + guide cut. POS/one-time revenue timing, not subscription, is what breaks.
  • Price ran ~+18% from ~$92 (2026-06-23) to $108.98 (2026-07-10) into the print; now above Oppenheimer $100 and near Piper $110, below consensus $127.33 and Northland $159. Chasing extension into a binary is the trap here.
  • modeled forward P/E cut to ~55x from ~72x. Sell-side reworking the multiple lower while price runs.
  • AI-native modules (Revenue Intelligence, CRS) beta-stage 'later FY2027' — narrative real but early, not a core revenue driver yet.
  • Marriott PMS rollout (signed Dec 2022) is 2+ year, back-end loaded; management warned against expecting a 'perfect rollout cadence.'
  • Theme maturing, not accelerating: recovery re-rate part-played. Cleaner entry is a post-earnings hold above the $88-92 base or a 20-EMA pullback, not a pre-print chase.

Related · shared themes

HPE

Hewlett Packard Enterprise Company

AI-server and enterprise-networking pivot is real at the theme level, but HPE's own chart broke: the record +25% Q2 FY26 blowoff (2026-06-02, ATH $64.25) fully round-tripped, the ~$48 pre-print shelf failed (last observed close $43.71 on 6/26), and nothing is dated until the Q3 print in early September. A fresh buy here catches the breakdown, not a base.

LOW

NTAP

NetApp, Inc.

NetApp's first genuine AI re-rating (2026-05-28 Q4 print) is now digesting — the ~35% gap to $192.83 has round-tripped to the ~$150 breakout-retest zone by 2026-06-26. FY27 revenue guided only +8%, no company binary until ~late-August Q1. Maturing AI-storage laggard to DELL/HPE; whether it holds the reclaimed 26-year ceiling ($148.63) decides the next leg.

LOW

SNOW

Snowflake Inc.

The June digestion resolved upward, not downward — SNOW cleared the ~$244 June high and printed a fresh 52-week high at $284.99 before settling at $268.90 (2026-07-17). Q1 FY27 product revenue re-accelerated to +34% and the street is still chasing (RBC $313 on 2026-07-17, KeyBanc $325 on 2026-07-16, consensus $292.53). The continuation leg runs into a 5-week catalyst vacuum until the 2026-08-26 Q2 print.

HIGH

SYRE

Spyre Therapeutics, Inc.

Two of three lead binaries (SPY001, SPY002 anti-TL1A) printed potential best-in-class; the stock absorbed a ~$399.7M director-fund block sale and sits back near its ~$102 ATH (~$95). Next legs — SPY003 IL-23 Part A (guided mid-2026, overdue) and SPY072 RA topline (accelerated to Q3) — are the near-term binaries. Platform de-risked, but distribution flags plus ~1:1 R/R to $100–135 targets argue probe-only into an all-time high.

LOW

See also · stocks to watch